General
Preferred name
EPZ020411
Synonyms
EPZ020411 HCl ()
EPZ020411 2HCl (1700663-41-7(free base)) ()
CS-5006 ()
HY-12970 ()
49L ()
EPZ020411 (hydrochloride) ()
EPZ020411 2HCl ()
EPZ020411 hydrochloride ()
P&D ID
PD044017
CAS
1700663-41-7
2070015-25-5
Tags
available
probe
Probe info
Probe type
P&D approved
experimental probe
Probe selectivity
protein-selective
Probe sources
Chemical Probes.org
High-quality chemical probes
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
COMMENT Selectivity over some other isoforms of arginine methyltransferase is limited 10 - 20 fold. No data is available on CNS exposure of EPZ02041. Jun 12 2016 - 4:05am; EPZ020411 is not greatly selective for PRMT6 over PRMT1 or PRMT8 in vitro. PRMT6 is the only PRMT known to methylate the H3R2 position, and EPZ020411 can be used as a probe to assess the functionality of this post-translational modification. While this compound shows poor bioavailability following oral dosing (<5%), subcutaneous (SC) dosing results in significant plasma levels, making this compound suitable for in vivo studies of the H3R2 mark using SC dosing. Jun 19 2016 - 6:58pm; EPZ020411 is a potent inhibitor of PRMT6 in biochemical (IC50 = 10 nM) and cellular (IC50 = 600 nM) assays EPZ020411 is selective against the related enzymes PRMT3, PRMT4, PRMT5, and PRMT7 in a biochemical assay, and relatively selective against PRMT1 and PRMT8, in biochemical (IC50's = 100 and 200 nM, respectively) and cellular assays (for PRMT1). Even though EPZ020411 is selective within the PRMT family, there is no information on other relevant human methyltransferases. (See 10.1021/acs.jmedchem.5b01772  and 10.1021/acschembio.5b00839 for examples of PRMT6 inhibitors profiled vs. other methyltransferases). In vivo EPZ020411 is 65% bioavailable following 5 mg/kg s.c. administration. Unfortunately, the unbound blood concentration of EPZ020411 is above the H3R2-methylation IC50 (cellular assay) for less than 6h. Additional studies will be required to define if this exposure is enough for a relevant pharmacological effect in vivo. Mar 12 2020 - 12:00pm
DESCRIPTION EPZ020411 is a selective inhibitor of PRMT6 with an IC50 of 10 nM, has >10 folds selectivity for PRMT6 over PRMT1 and PRMT8. EPZ020411 can be used for the research of cancer[1][2].
DESCRIPTION EPZ020411 hydrochloride is a selective inhibitor of PRMT6 with an IC50 of 10 nM, it has >10 folds selectivity for PRMT6 over PRMT1 and PRMT8. EPZ020411 hydrochloride can be used for the research of cancer[1][2].
PRICE 218
MOA Inhibitor (Chemical Probes.org)
DESCRIPTION EPZ020411 hydrochloride is a selective and potent small molecule PRMT6 inhibitor with an IC50 value of 10 nM. (TargetMol Bioactive Compound Library)
Cell lines
2
Organisms
0
Compound Sets
10
AdooQ Bioactive Compound Library
A16377
Cayman Chemical Bioactives
19160
Chemical Probes.org
epz020411
Drug Repurposing Hub
EU-OPENSCREEN Bioactive Compound Library
EOS100561
High-quality chemical probes
PD044017
MedChem Express Bioactive Compound Library
HY-12970
HY-12970A
Novartis Chemogenetic Library (NIBR MoA Box)
Selleckchem Bioactive Compound Library
epz020411
TargetMol Bioactive Compound Library
T22325
External IDs
15
Properties
(calculated by RDKit )
Molecular Weight
442.29
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
12
Ring Count
4
Aromatic Ring Count
2
cLogP
3.47
TPSA
71.64
Fraction CSP3
0.64
Chiral centers
0.0
Largest ring
6.0
QED
0.52
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
PRMT1
PRMT6
PRMT8
Apoptosis
Histone Methyltransferase,PRMT
MOA
Histone methyltransferase
PRMT6 inhibitor
PRMT6 gene inhibitor
protein arginine N-methyltransferase inhibitor
Pathway
Chromatin/Epigenetic
Member status
member
Target class
Epigenetics
Epigenetic
Target subclass
Protein methyltransferase
Source data